Compare $AURA vs $FTH | Chartloom

Compare

$AURA vs $FTH

Aura Biosciences Inc · Faeth Therapeutics, Inc

AURA

Aura Biosciences Inc

FTH

Faeth Therapeutics, Inc

Compare $AURA vs $FTH

Comparing Aura Biosciences Inc and Faeth Therapeutics, Inc

AURAAura Biosciences Inc

FTHFaeth Therapeutics, Inc

AURAAura Biosciences Inc

Market cap

$676M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

23.4%

52W performance

7.4%

FCF yield

-15.3%

FTHFaeth Therapeutics, Inc

Market cap

$671M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

79.1%

52W performance

79.1%

FCF yield

-5.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AURA

FTH

Detailed metrics comparison

AURA

Aura Biosciences Inc

FTH

Faeth Therapeutics, Inc

Market Cap

AURA$676M

FTH$671M

Enterprise Value

AURA$609M

FTH$644M

Price

AURA$6.54

FTH$26.03

P/E Ratio

AURAN/A

FTHN/A

P/S Ratio

AURA0.00x

FTH0.00x

EV/Sales

AURA0.00x

FTH0.00x

EV/EBITDA

AURA0.00x

FTH0.00x

P/B Ratio

AURA2.00x

FTH4.08x

P/FCF Ratio

AURAN/A

FTHN/A

EV/FCF

AURA-5.89x

FTH-19.02x

PEG Ratio

AURAN/A

FTHN/A

Forward P/E (NTM)

AURAN/A

FTHN/A

Forward P/S (NTM)

AURAN/A

FTHN/A

Revenue (TTM)

AURA$0

FTH$0

Revenue Growth (YoY)

AURAN/A

FTHN/A

Forward Rev Growth

AURA591.6%

FTH77.6%

Gross Margin (TTM)

AURA0.0%

FTH0.0%

Operating Margin (TTM)

AURA0.0%

FTH0.0%

EBITDA Margin (TTM)

AURA0.0%

FTH0.0%

Net Margin (TTM)

AURA0.0%

FTH0.0%

FCF Margin (TTM)

AURAN/A

FTHN/A

Net Income (TTM)

AURA$-131M

FTH$-196M

FCF (TTM)

AURA$-103M

FTH$-34M

EPS (TTM)

AURA-$1.38

FTH-$34.65

ROE (TTM)

AURA-7318.0%

FTH-18959.0%

ROA (TTM)

AURA-6200.0%

FTH-17568.0%

ROIC (TTM)

AURA-7318.0%

FTH-18946.0%

Cash

AURA$68M

FTH$27M

Debt

AURA$0

FTH$0

Net Cash/Debt

AURA$68M

FTH$27M

Current Ratio (TTM)

AURA16.82x

FTH19.69x

Quick Ratio (TTM)

AURA16.69x

FTH19.55x

Debt/Equity (TTM)

AURA0.00x

FTH0.00x

Debt/Assets (TTM)

AURA0.0%

FTH0.0%

Interest Coverage (TTM)

AURAN/A

FTHN/A

Net Debt/EBITDA (TTM)

AURA0.00x

FTH0.00x

Beta

AURA0.45

FTH2.05

52W Performance

AURA7.4%

FTH79.1%

YTD Performance

AURA23.4%

FTH79.1%

% from 52W High

AURA-31.4%

FTH-38.2%

% from 52W Low

AURA38.3%

FTH93.8%

Asset Turnover (TTM)

AURA0.00x

FTH0.00x

FCF Yield (TTM)

AURA-15.3%

FTH-5.0%

Earnings Yield (TTM)

AURA-19.4%

FTH-29.1%

Dividend Yield (TTM)

AURAN/A

FTHN/A

Rule of 40

AURA0.0

FTH0.0

EV/GP/RG

AURAN/A

FTHN/A

Ticker research

View AURA research View FTH research

Metric	AURA Aura Biosciences Inc	FTH Faeth Therapeutics, Inc
Market & Valuation
Market Cap	$676M	$671M
Enterprise Value	$609M	$644M
Price	$6.54	$26.03
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.00x	4.08x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.89x	-19.02x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	591.6%	77.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-131M	$-196M
FCF (TTM)	$-103M	$-34M
EPS (TTM)	-$1.38	-$34.65
ROE (TTM)	-7318.0%	-18959.0%
ROA (TTM)	-6200.0%	-17568.0%
ROIC (TTM)	-7318.0%	-18946.0%
Financial Health
Cash	$68M	$27M
Debt	$0	$0
Net Cash/Debt	$68M	$27M
Current Ratio (TTM)	16.82x	19.69x
Quick Ratio (TTM)	16.69x	19.55x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.45	2.05
52W Performance	7.4%	79.1%
YTD Performance	23.4%	79.1%
% from 52W High	-31.4%	-38.2%
% from 52W Low	38.3%	93.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-15.3%	-5.0%
Earnings Yield (TTM)	-19.4%	-29.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AURA research	View FTH research

Valuation

P/S Ratio

AURA

0.00x

FTH

0.00x

EV/FCF

FTH

-19.02x

AURA

-5.89x

Growth & revenue

Forward Revenue Growth

AURA

591.6%

FTH

77.6%

Profitability & performance

Gross Margin

AURA

0.0%

FTH

0.0%

ROE

AURA

-7318.0%

FTH

-18959.0%

FCF Yield %

FTH

-5.0%

AURA

-15.3%

52-Week Performance

FTH

79.1%

AURA

7.4%

Detailed metrics comparison

AURA

Aura Biosciences Inc

FTH

Faeth Therapeutics, Inc

Market Cap

AURA$676M

FTH$671M

Enterprise Value

AURA$609M

FTH$644M

Price

AURA$6.54

FTH$26.03

P/E Ratio

AURAN/A

FTHN/A

P/S Ratio

AURA0.00x

FTH0.00x

EV/Sales

AURA0.00x

FTH0.00x

EV/EBITDA

AURA0.00x

FTH0.00x

P/B Ratio

AURA2.00x

FTH4.08x

P/FCF Ratio

AURAN/A

FTHN/A

EV/FCF

AURA-5.89x

FTH-19.02x

PEG Ratio

AURAN/A

FTHN/A

Forward P/E (NTM)

AURAN/A

FTHN/A

Forward P/S (NTM)

AURAN/A

FTHN/A

Revenue (TTM)

AURA$0

FTH$0

Revenue Growth (YoY)

AURAN/A

FTHN/A

Forward Rev Growth

AURA591.6%

FTH77.6%

Gross Margin (TTM)

AURA0.0%

FTH0.0%

Operating Margin (TTM)

AURA0.0%

FTH0.0%

EBITDA Margin (TTM)

AURA0.0%

FTH0.0%

Net Margin (TTM)

AURA0.0%

FTH0.0%

FCF Margin (TTM)

AURAN/A

FTHN/A

Net Income (TTM)

AURA$-131M

FTH$-196M

FCF (TTM)

AURA$-103M

FTH$-34M

EPS (TTM)

AURA-$1.38

FTH-$34.65

ROE (TTM)

AURA-7318.0%

FTH-18959.0%

ROA (TTM)

AURA-6200.0%

FTH-17568.0%

ROIC (TTM)

AURA-7318.0%

FTH-18946.0%

Cash

AURA$68M

FTH$27M

Debt

AURA$0

FTH$0

Net Cash/Debt

AURA$68M

FTH$27M

Current Ratio (TTM)

AURA16.82x

FTH19.69x

Quick Ratio (TTM)

AURA16.69x

FTH19.55x

Debt/Equity (TTM)

AURA0.00x

FTH0.00x

Debt/Assets (TTM)

AURA0.0%

FTH0.0%

Interest Coverage (TTM)

AURAN/A

FTHN/A

Net Debt/EBITDA (TTM)

AURA0.00x

FTH0.00x

Beta

AURA0.45

FTH2.05

52W Performance

AURA7.4%

FTH79.1%

YTD Performance

AURA23.4%

FTH79.1%

% from 52W High

AURA-31.4%

FTH-38.2%

% from 52W Low

AURA38.3%

FTH93.8%

Asset Turnover (TTM)

AURA0.00x

FTH0.00x

FCF Yield (TTM)

AURA-15.3%

FTH-5.0%

Earnings Yield (TTM)

AURA-19.4%

FTH-29.1%

Dividend Yield (TTM)

AURAN/A

FTHN/A

Rule of 40

AURA0.0

FTH0.0

EV/GP/RG

AURAN/A

FTHN/A

Ticker research

View AURA research View FTH research

Metric	AURA Aura Biosciences Inc	FTH Faeth Therapeutics, Inc
Market & Valuation
Market Cap	$676M	$671M
Enterprise Value	$609M	$644M
Price	$6.54	$26.03
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.00x	4.08x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.89x	-19.02x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	591.6%	77.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-131M	$-196M
FCF (TTM)	$-103M	$-34M
EPS (TTM)	-$1.38	-$34.65
ROE (TTM)	-7318.0%	-18959.0%
ROA (TTM)	-6200.0%	-17568.0%
ROIC (TTM)	-7318.0%	-18946.0%
Financial Health
Cash	$68M	$27M
Debt	$0	$0
Net Cash/Debt	$68M	$27M
Current Ratio (TTM)	16.82x	19.69x
Quick Ratio (TTM)	16.69x	19.55x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.45	2.05
52W Performance	7.4%	79.1%
YTD Performance	23.4%	79.1%
% from 52W High	-31.4%	-38.2%
% from 52W Low	38.3%	93.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-15.3%	-5.0%
Earnings Yield (TTM)	-19.4%	-29.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AURA research	View FTH research